Abstract | AIM: To compare the efficacy of 0.75% ropivacaine with 3% mepivacaine for pain control in the first 24 hours after surgical removal of lower third molars, using a quantitative measurement such as VAS. The secondary objective involved rescue analgesia. METHODS: Forty-five patients, 21 females and 24 males, mean age 23,2 ± 3 years, underwent surgical removal of third molars in two separate sessions. A split-mouth design was chosen, so each patient underwent both the first and second surgeries, having for each extraction a different anesthetic. The second extraction was carried out 1 month later. Parameters evaluated were: onset of anesthesia, duration of surgery, lip numbness, timing of pain appearance and first analgesic intake. RESULTS: CONCLUSIONS: With the use of ropivacaine, the discomfort caused by prolonged lip numbness is counterbalanced by less postoperative discomfort after surgery. In addition, when compared with other long-acting anesthetics, ropivacaine ensures a safer anesthetic profile for medically complex patients.
|
Authors | Vito Crincoli, Gianfranco Favia, Luisa LImongelli, Angela Tempesta, Nicola Brienza |
Journal | International journal of medical sciences
(Int J Med Sci)
Vol. 12
Issue 11
Pg. 862-6
( 2015)
ISSN: 1449-1907 [Electronic] Australia |
PMID | 26640405
(Publication Type: Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Amides
- Anesthetics, Local
- Ropivacaine
- Mepivacaine
|
Topics |
- Adult
- Amides
(therapeutic use)
- Anesthetics, Local
(therapeutic use)
- Female
- Humans
- Male
- Mepivacaine
(therapeutic use)
- Molar, Third
(surgery)
- Pain, Postoperative
(drug therapy)
- Prospective Studies
- Ropivacaine
|